Impact of Deep Endometriosis Surgery on Bladder Function

September 10, 2014 updated by: Laterza Rosa Maria, Medical University of Vienna

It has been demonstrated that ligaments, both cardinal and uterosacral contain a considerable amount of autonomic nerve tissues. The resection of deep infiltrating endometriotic nodules at the level of the uterosacral ligaments or the rectovaginal space is supposed to damage the supplying autonomic nerve fibers of the lower urinary tract. The bladder receives motor and sensitive innervations from both the sympathetic fibers, most of which arise from the hypogastric plexuses and nerves, and the parasympathetic fibers, which arise from the pelvic splanchnic nerves and the inferior hypogastric plexus; therefore, even bladder function may be impaired in women affected by deep endometriosis.

Very few data have been published regarding the urodynamic functional evaluation of bladder in patient with deep endometriosis.So far, it is unknown if the surgery itself causes the postoperative bladder dysfunction or if the surgery unmasks a subclinically pre-existing detrusor pathology.

Since the urinary postoperative complications have a strong impact on quality of life of the deep endometriosis patients and often requires management (due to a poor spontaneous remission), it is crucial a better understanding of the problem. That will help for a more appropriate pre-operative counselling.

Aims of this study are to evaluate the bladder function before and after deep endometriosis surgery, using standardized validated instruments and to correlate the localisation of the endometriosis lesion, the type/area of surgical dissection with the postoperative bladder function.

This is a prospective multicenter cohort study involving the Department of General Gynaecology and Gynecological Oncology of Medical University of Vienna (Austria) and the Department of Obstetrics and Gynaecology of Insubria University, Varese (Italy).

A total of 50 patients are planned to be included. The study protocol consider a Preoperative Assessment (clinical examination, transvaginal pelvic ultrasound, preoperative specific questionnaire including obstetric, medical, and surgical history and standardized questions on pelvic floor dysfunctions, standardized instrumental assessment of the pelvic floor) a Intraoperative Assessment (during laparoscopy, the localizations of endometriotic lesions recorded and identified by anatomical sites, numbers, and depth of infiltration). Before and 3 months after surgery a Urodynamic assessment is planned.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

- Patients with confirmed diagnosis of deep infiltrating endometriosis requiring surgical treatment

Description

Inclusion Criteria:

  • Patients with confirmed diagnosis of deep infiltrating endometriosis requiring surgical treatment
  • Patient planned to be submitted to laparoscopic surgery finalize to eradicate the endometriosis pathology
  • Naïve patients for OAB treatment.
  • Patients must be capable of independent toileting
  • Patients must be able to fully understand all study procedures and to provide written informed consent to study participation

Exclusion Criteria:

  • Patient previously submitted to pelvic surgery for any urogynaecological disease;
  • Patients previously submitted to DE surgery
  • Patient with documented clinical, instrumental, or laparoscopic preoperative diagnosis of bladder endometriosis;
  • Patient with documented urinary tract infection
  • Patient with history of diabetes mellitus, psychiatric, or neurological disease;
  • Pregnant patients
  • Patients < 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Deep endometriosis patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urodynamic assessment after deep infiltrating endometriosis surgery
Time Frame: 2 years
to evaluate the bladder function before and after deep endometriosis surgery (Unit of Measure: First Desire (ml) from Urodynamic Assessment)
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bladder symptoms after surgery for deep infiltrating endometriosis
Time Frame: 2 years
using standardized validated questionnaires -OABQ short form, ICIQ short form questionnaire, micturition diary.
2 years
correlation between localisation of the endometriosis lesion and postoperative bladder function.
Time Frame: 2 years
to correlate the localisation of the endometriosis lesion, the type/area of surgical dissection with a specific urodynamic pattern and/or a specific low urinary tract symptom
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (ACTUAL)

June 1, 2014

Study Registration Dates

First Submitted

August 28, 2014

First Submitted That Met QC Criteria

September 10, 2014

First Posted (ESTIMATE)

September 12, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

September 12, 2014

Last Update Submitted That Met QC Criteria

September 10, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ENDOBLAD 1057/2014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deep Infiltrating Endometriosis

Subscribe